AU562210B2 - 3-amino quinuclidine derivatives - Google Patents

3-amino quinuclidine derivatives

Info

Publication number
AU562210B2
AU562210B2 AU16507/83A AU1650783A AU562210B2 AU 562210 B2 AU562210 B2 AU 562210B2 AU 16507/83 A AU16507/83 A AU 16507/83A AU 1650783 A AU1650783 A AU 1650783A AU 562210 B2 AU562210 B2 AU 562210B2
Authority
AU
Australia
Prior art keywords
formula
compounds
och
derivatives
takes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU16507/83A
Other languages
English (en)
Other versions
AU1650783A (en
Inventor
Nicole Dorme
Thierry Imbert
Michel Langlois
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delalande SA filed Critical Delalande SA
Publication of AU1650783A publication Critical patent/AU1650783A/en
Application granted granted Critical
Publication of AU562210B2 publication Critical patent/AU562210B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU16507/83A 1982-07-02 1983-07-01 3-amino quinuclidine derivatives Expired AU562210B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8211670 1982-07-02
FR8211670A FR2529548A1 (fr) 1982-07-02 1982-07-02 Nouveaux derives de l'amino-3 quinuclidine, leur procede et leur application en therapeutique

Publications (2)

Publication Number Publication Date
AU1650783A AU1650783A (en) 1984-01-05
AU562210B2 true AU562210B2 (en) 1987-06-04

Family

ID=9275643

Family Applications (1)

Application Number Title Priority Date Filing Date
AU16507/83A Expired AU562210B2 (en) 1982-07-02 1983-07-01 3-amino quinuclidine derivatives

Country Status (9)

Country Link
US (1) US4657911A (enExample)
EP (1) EP0099789B1 (enExample)
JP (1) JPS5921684A (enExample)
AU (1) AU562210B2 (enExample)
CA (1) CA1265802A (enExample)
DE (1) DE3372769D1 (enExample)
ES (1) ES524128A0 (enExample)
FR (1) FR2529548A1 (enExample)
ZA (1) ZA834704B (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU575929B2 (en) * 1984-04-06 1988-08-11 A.H. Robins Company, Incorporated N-(3-quinuclidinyl) benzamides and thiobenzamides
AU589592B2 (en) * 1985-02-04 1989-10-19 A.H. Robins Company, Incorporated Process for the preparation of 2-alkoxy-n-(1-azabicyclo (2.2.2)octan-3-yl) amino-benzamides
AU597036B2 (en) * 1986-03-05 1990-05-24 A.H. Robins Company, Incorporated Method of using 2-alkoxy-N-(1-azabicyclo(2.2.2)oct-3-yl) benzamide-N-oxides to control emesis caused by anticancer drugs

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531083B1 (fr) * 1982-06-29 1986-11-28 Sandoz Sa Nouveaux derives de la piperidine, leur preparation et leur utilisation comme medicaments
JPS5936675A (ja) * 1982-07-13 1984-02-28 サンド・アクチエンゲゼルシヤフト 二環性複素環式カルボン酸アザビシクロアルキルエステルまたはアミド
US5175173A (en) * 1983-12-22 1992-12-29 Sun Jung Hui Carboxamides useful as antiemetic or antipsychotic agents
US4888353A (en) * 1986-02-28 1989-12-19 Erbamont, Inc. Carboxamides useful as antiemetic or antipsychotic agents
US4605652A (en) * 1985-02-04 1986-08-12 A. H. Robins Company, Inc. Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
GB8511988D0 (en) * 1985-05-11 1985-06-19 Beecham Group Plc Compounds
GB8520616D0 (en) * 1985-08-16 1985-09-25 Beecham Group Plc Compounds
GB8525844D0 (en) * 1985-10-19 1985-11-20 Beecham Group Plc Compounds
US4717563A (en) * 1986-03-05 1988-01-05 A. H. Robins Company, Inc. 2-alkoxy-N-(1-azabicyclo(2.2.2)oct-3-yl) benzamides and thiobenzamides in a method for alleviating emesis caused by non-platinum anticancer drugs
HU202108B (en) * 1986-07-30 1991-02-28 Sandoz Ag Process for producing pharmaceutical compositions containing serotonine antqgonistic derivatives of indol-carboxylic acid or imidazolyl-methyl-carbazol
US4772459A (en) * 1986-09-09 1988-09-20 Erbamont, Inc. Method for controlling emesis caused by chemotherapeutic agents and antiemetic agents useful therein
ES2051753T3 (es) * 1986-12-16 1994-07-01 Robins Co Inc A H N-(1-azabiciclo(2.2.2)octo-3-il) benzamidas y tiobenzamidas ansioliticas.
US5246941A (en) * 1986-12-17 1993-09-21 Glaxo Group Limited Method for the treatment of depression
US5237066A (en) * 1987-02-04 1993-08-17 Delande S.A. Enantiomers of absolute configuration S of amide derivatives of 3-aminoquinuclidine, the process for preparing them and their application in therapy
FR2610323B1 (fr) * 1987-02-04 1989-06-23 Delalande Sa Enantiomeres de configuration absolue s de derives amide de l'amino-3 quinuclidine, leur procede de preparation et leur application en therapeutique
GB8718345D0 (en) * 1987-08-03 1987-09-09 Fordonal Sa N-substituted benzamides
GB8720805D0 (en) * 1987-09-04 1987-10-14 Naylor R J 2-alkoxy-n-(1-azabicyclo(2 2 2)oct-3-yl)benzamides & thiobenzamides
EP0311724A1 (en) * 1987-10-16 1989-04-19 Synthelabo Anxiolytic-R-N-(1-azabicyclo[2.2.2]oct-3-yl) benzamides and thiobenzamides
FR2625678B1 (fr) * 1988-01-13 1991-06-07 Delalande Sa Agents anorexigenes a base de n-(quinuclidin-3-yl)-benzamides ou thiobenzamides
US4863919A (en) * 1988-02-01 1989-09-05 A. H. Robins Company, Incorporated Method of enhancing memory or correcting memory deficiency with arylamido(and arylthiomido)-azabicycloalkanes
ATE85217T1 (de) * 1988-08-04 1993-02-15 Synthelabo Antischizophren-wirksame s-n-(1-azabicyclo (2.2.2.>oct-3-yl)benzamide und thiobenzamide.
MX18467A (es) * 1988-11-23 1993-07-01 Pfizer Agentes terapeuticos de quinuclidinas
GB8904551D0 (en) * 1989-02-28 1989-04-12 Glaxo Group Ltd Chemical compounds
US5290938A (en) * 1989-09-15 1994-03-01 Chiron Laboratories A.S. Preparation of S-(-)- and R-(+)-N-(quinuclidinyl-3)-amide
NO168529C (no) * 1989-09-15 1992-03-04 Chiron Lab As Fremgangsmaate for fremstilling av s-(-) og r-(+)-n-(quinuclidinyl-3)-amider.
US5070095A (en) * 1990-12-12 1991-12-03 A. H. Robins Company, Incorporated Substituted 4-(amidino)benzamides of 1-azabicyclo[2.2.2]octan-3- and -4-amine as gastric prokinetic, antiemetic, and anxiolytic agents
GB9027487D0 (en) * 1990-12-19 1991-02-06 Beecham Group Plc Pharmaceuticals
US5084460A (en) * 1990-12-24 1992-01-28 A. H. Robins Company, Incorporated Methods of therapeutic treatment with N-(3-ouinuclidinyl)-2-hydroxybenzamides and thiobenzamides
US5138060A (en) * 1991-01-03 1992-08-11 Pfizer Inc. Process and intermediates for preparing azabicyclo(2.2.2)octan-3-imines
US5236931A (en) * 1992-03-26 1993-08-17 A. H. Robins Company, Incorporated 2-substituted benzamide and benzoate derivatives of 3-aminoquinuclidine and 3-quinuclidinol
US5273972A (en) * 1992-03-26 1993-12-28 A. H. Robins Company, Incorporated [(2-diakylaminomethyl)-3-quinuclidinyl]-benzamides and benzoates
FR2719842B1 (fr) * 1994-05-10 1996-06-07 Synthelabo Sels quaternaires de dérivés de 1-azabicyclo [2.2.2] octane, leur préparation et leur application en thérapeutique.
US5723103A (en) * 1994-12-09 1998-03-03 Vanderbilt University Substituted benzamides and radioligand analogs and methods of use
SE0000540D0 (sv) * 2000-02-18 2000-02-18 Astrazeneca Ab New compounds
AU2001282874A1 (en) 2000-08-18 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
US6492385B2 (en) 2000-08-18 2002-12-10 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6486172B2 (en) 2000-08-18 2002-11-26 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
WO2002017358A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists)
WO2002015662A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists
PE20021019A1 (es) 2001-04-19 2002-11-13 Upjohn Co Grupos azabiciclicos sustituidos
MXPA04000779A (es) * 2001-08-24 2004-04-20 Pharmacia & Up John Company 7-aza[2.2.1]bicicloheptanos sustituidos con arilo para el tratamiento de enfermedades.
US6852716B2 (en) 2002-02-15 2005-02-08 Pfizer Inc Substituted-aryl compounds for treatment of disease
MXPA04007083A (es) * 2002-02-20 2004-10-29 Upjohn Co Compuestos azabiciclicos para el tratamiento de enfermedades.
WO2004013137A1 (en) 2002-08-01 2004-02-12 Pharmacia & Upjohn Company Llc 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity
MXPA06007026A (es) * 2003-12-22 2006-08-31 Astrazeneca Ab Ligandos del receptor nicotinico de acetilcolina.
WO2008028903A2 (en) 2006-09-04 2008-03-13 Neurosearch A/S Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
WO2008119710A1 (en) * 2007-03-30 2008-10-09 Neurosearch A/S Two-phase test method for characterizing the effect of a chemical compound on a test animal and maze for carrying out the method
ES2432618T3 (es) 2009-05-20 2013-12-04 Inserm (Institut National De La Santé Et De La Recherche Medicale) Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular
EP2432467B1 (en) 2009-05-20 2018-02-21 INSERM (Institut National de la Santé et de la Recherche Médicale) Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE331841B (enExample) * 1967-05-23 1971-01-18 Astra Ab
US3534053A (en) * 1967-05-24 1970-10-13 American Home Prod Quinuclidine derivatives
US3702324A (en) * 1970-06-24 1972-11-07 Stanford Research Inst 3,4,5-trimethoxybenzamides of substituted anilines and of alkylpiperidines
FR2183565B1 (enExample) * 1972-05-10 1975-12-26 Cerm Cent Europ Rech Mauvernay
CH614709A5 (enExample) * 1975-09-25 1979-12-14 Ciba Geigy Ag
NL7611713A (nl) * 1975-11-03 1977-05-05 Thomae Gmbh Dr K Werkwijze voor de bereiding van verbindingen en preparaten met waardevolle farmacologische eigen- schappen.
FR2329226A1 (fr) * 1975-11-03 1977-05-27 Ipa Ind Plastique Aquitain Porte-documents ou pochette
US4203989A (en) * 1979-04-30 1980-05-20 G. D. Searle & Co. Anti-diarrheal diaryl-(1-azabicyclo(2.2.2)octan-2-yl)-alkanols and related compounds

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU575929B2 (en) * 1984-04-06 1988-08-11 A.H. Robins Company, Incorporated N-(3-quinuclidinyl) benzamides and thiobenzamides
AU589592B2 (en) * 1985-02-04 1989-10-19 A.H. Robins Company, Incorporated Process for the preparation of 2-alkoxy-n-(1-azabicyclo (2.2.2)octan-3-yl) amino-benzamides
AU597036B2 (en) * 1986-03-05 1990-05-24 A.H. Robins Company, Incorporated Method of using 2-alkoxy-N-(1-azabicyclo(2.2.2)oct-3-yl) benzamide-N-oxides to control emesis caused by anticancer drugs

Also Published As

Publication number Publication date
US4657911A (en) 1987-04-14
EP0099789A1 (fr) 1984-02-01
ES8403897A1 (es) 1984-04-16
ES524128A0 (es) 1984-04-16
JPS5921684A (ja) 1984-02-03
JPH0587516B2 (enExample) 1993-12-16
DE3372769D1 (en) 1987-09-03
EP0099789B1 (fr) 1987-07-29
CA1265802A (en) 1990-02-13
ZA834704B (en) 1984-03-28
AU1650783A (en) 1984-01-05
FR2529548B1 (enExample) 1985-04-19
FR2529548A1 (fr) 1984-01-06

Similar Documents

Publication Publication Date Title
AU1650783A (en) 3-amino quinuclidine derivatives
AU2060283A (en) Alpha-aryl-1h-azolyl-1-ethanol derivatives
AU1425183A (en) I-piperazine derivatives
AU2290088A (en) Halogen-aniline derivatives
AU563285B2 (en) Propynylaminoisoxazole derivatives
AU2299983A (en) Sulphonamido-benzamide derivatives
AU555417B2 (en) Benzodiazipine derivatives
AU2174783A (en) 3-thiovinyl cephalosporin derivatives
AU562776B2 (en) Cephalosporin derivatives
AU1800483A (en) Desoxyuridine derivatives
AU558772B2 (en) Vinylthioacetamido oxacephalosporin derivatives
AU1561083A (en) Pyrazolopyridine derivatives
AU1631083A (en) Trans-delta2-prostoglandin d derivatives
AU572105B2 (en) N-substituted-phenothiazine derivatives
AU2387584A (en) Azabicyclic derivatives
AU1962583A (en) Thiatriazine derivatives
AU586037B2 (en) Substituted ethanediimidamides
AU561694B2 (en) Pyridyloxybenzanilide derivatives
AU565078B2 (en) Acridanone derivatives
AU1867883A (en) Sulfamoylbenzophenone derivatives
AU1382583A (en) Indolizidinylbenzamide derivatives
AU560306B2 (en) 3-azetidinylethyl-1-phenyl-2-imidazolidinone derivatives
AU554197B2 (en) Eburnane derivatives
AU546100B2 (en) 3-amino substituted steroid derivatives
AU557503B2 (en) Naphthalenamine derivatives

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired